Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neuroblastoma 14Ganglioneuroblastoma 3Glioblastoma 2Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Medulloblastoma 1Lung Neoplasms 1Leukemia, Myelomonocytic, Juvenile 1Leukemia 1Gliosarcoma 1Glioma 1Ependymoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

Mycophenolic Acid 17fludarabine phosphate 16Cyclophosphamide 15Whole-Body Irradiation 10Tacrolimus 10Melphalan 10Peripheral Blood Stem Cell Transplantation 9Filgrastim 9Cyclosporine 9Busulfan 9Antilymphocyte Serum 8Granulocyte Colony-Stimulating Factor 7thymoglobulin 6Methotrexate 6Cord Blood Stem Cell Transplantation 5fludarabine 4Thiotepa 4Radiotherapy 4Methylprednisolone 4Etoposide 4Cytarabine 4Stem Cell Transplantation 3Rituximab 3Clofarabine 3Transplantation 2Sirolimus 2Methylprednisolone Hemisuccinate 2Methylprednisolone Acetate 2Etanercept 2Alemtuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Myelomonocytic, Juvenile × Isotretinoin × Clear all
NCT00609739 2017-12-28

Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation

Masonic Cancer Center, University of Minnesota

Phase 1/2 Terminated
1 enrolled 7 charts
Other hematologic neoplasm

Leukemia, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡